The Company
The Company
Projects
Projects
Investors
Investors
Corporate Governance
Corporate Governance
Media
Media
Contact
Contact
- - Office
- - Investors
- - Media

Svenska

Promore Pharma in Brief
Vision and Strategy
Market
Team
Board of Directors

Project Overview
Ensereptide – Prevention of Scarring
Ropocamptide – Healing of Chronic Wounds
Publications

Promore Pharma on Nasdaq First North Growth Market
- Certified Adviser
The Share
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe

Corporate Governance

Corporate Governance
General Meeting
- General Meetings
Nomination Committee
- Nomination Committees
The Board of Directors
- Board of Directors
The Management
- Management
Remunerations and Remuneration Committee
Auditor and Audit Committee
Articles of Association
Certificate of Registration

Press Releases
Imagebank
Promore Pharma in Media
Subscribe

Office
Investors
Media

Corporate Governance

Corporate Governance
General Meeting
- General Meetings
Nomination Committee
- Nomination Committees
The Board of Directors
- Board of Directors
The Management
- Management
Remunerations and Remuneration Committee
Auditor and Audit Committee
Articles of Association
Certificate of Registration

May 27, 2021

Extraordinary General Meeting 2021

Promore Pharma AB (publ) held an Extraordinary General Meeting in connection with the Company’s Annual General Meeting on Thursday 27 May 2021.

Documents

Report from an extra General Meeting of Promore Pharma AB held on 27 May 2021May 27, 2021English
Notice to convene EGM in Promore Pharma AB
Resolution to issue shares
Advance voting form EGM 2021
BOD statement in accordance with Chapter 13 Section 6
Auditor's Statement in accordance with Chapter 13 s6
Proxy form
Minutes of Extraordinary General Meeting 2021

Promore Pharma in Brief
Vision and Strategy
Market
Team
Board of Directors

Project Overview
Ensereptide – Prevention of Scarring
Ropocamptide – Healing of Chronic Wounds
Publications

Promore Pharma on Nasdaq First North Growth Market
The Share
Financial Reports
Press Releases
Prospectuses
Presentations and Events
Calendar
Subscribe

Corporate Governance

Corporate Governance
General Meeting
Nomination Committee
The Board of Directors
The Management
Remunerations and Remuneration Committee
Auditor and Audit Committee
Articles of Association
Certificate of Registration

Press Releases
Imagebank
Promore Pharma in Media
Subscribe

Office
Investors
Media

Promore Pharma AB. Address: Fogdevreten 2, SE-171 65 Solna, Sweden. Phone: +46 8 124 548 59. E-mail: info@promorepharma.com. Registration number: 556639-6809.

Personal data
About cookies